Under the new policy, financial assistance has been increased to Rs 50 lakh per patient to improve treatment access
Lifts full-year outlook as obesity drug boom accelerates
Under the terms, Arcellx shareholders received $115 per share in cash plus a non-transferable contingent value right
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
The conference focuses on the latest advances in cancer diagnosis, treatment, and patient-centric care
The licensed intellectual property covers methods and designs for CAR constructs engineered to function in myeloid cell populations
A next-generation, cell-based immunotherapy, CAR-T therapy engineers a patient’s own immune cells to detect and destroy cancer
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
